Fourat Ridouani

Fourat Ridouani

Auto-generated profile, based on publicly available information

Fourat Ridouani

Memorial Sloan Kettering Cancer Center, United States

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
FRFourat Ridouani
Fourat Ridouani
TDThibaud Damy
Thibaud Damy
VTVania Tacher
Vania Tacher
Haytham DerbelHaytham Derbel
Haytham Derbel
FLFrançois Legou
François Legou
Jean-François DEUXJean-François DEUX
Jean-François DEUX
To assess the diagnostic and prognosis value of myocardial native T2 measurement in the distinction between Light-chain (AL) and Transthyretin (ATTR) cardiac amyloidosis (CA). Forty-four patients with CA (24 AL; 20 ATTR) and 40 healthy subjects underwent 1.5 T cardiovascular magnetic resonance (CMR). They all underwent T1 and T2 mapping (modified Look-Locker inversion recovery), cine and late gadolinium enhancement (LGE) imaging. The Query Amyloid Late Enhancement (QALE) score, myocardial native T2, T1 and extra cellular volume fraction (ECV) were calculated for all patients. Of the 44 patients, 36 (82%) exhibited enhancement on LGE images. Mean QALE score of AL (7.9 ± 6) and ATTR (10.5 ± 5) patients were similar (p = 0.6). Myocardial native T2 was significantly (p < 0.0001) higher in AL (63.2 ± 4.7 ms) than in ATTR (56.2 ± 3.1 ms) patients, and both higher (p < 0.001) than healthy subjects (51.1 ± 3.1 ms). Myocardial native T2 was highly correlated with myocardial native T1 (Spearman’s rho = 0.79; p < 0.001) and exhibited higher diagnostic performance than T1 to separate AL and ATTR patients: the area under curve (AUC) of T2 was 0.94 (95% CI: 0.86–1, p < 0.001) and the AUC of T1 was 0.77 (95% CI: 0.62–0.91, p = 0.03). Myocardial native T2 did not impact overall survival in patients (HR 1.03 (0.94–1.12); p = 0.53) in contrast to ECV that was the best predictor of outcome (HR 1.66 per 0.1 increase in ECV (1.24–2.22); p = 0.0006). Myocardial native T2 significantly is increased in CA, especially in AL patients in comparison to ATTR patients. Myocardial native T2 does not impact survival in CA patients in contrast to ECV that was the best predictor of outcome. Trial Registration and unique number: CNIL cardio 1778041. Date of registration: 20 December 2012.

10 August 2017 in European Radiology
Verified
Journal Article
Closed access
PDF file
VCvirgile chevance
virgile chevance
TDThibaud Damy
Thibaud Damy
VTVania Tacher
Vania Tacher
FLFrançois Legou
François Legou
FRFourat Ridouani
Fourat Ridouani
Jean-François DEUXJean-François DEUX
Jean-François DEUX

17 May 2017 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
VTVania Tacher
Vania Tacher
APArthur Petit
Arthur Petit
Haytham DerbelHaytham Derbel
Haytham Derbel
LNLuigi Novelli
Luigi Novelli
MVManuel Vitellius
Manuel Vitellius
HKHicham Kobeiter
Hicham Kobeiter

1 February 2016 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
VTVania Tacher
Vania Tacher
PDPascal Desgranges
Pascal Desgranges
KYKetsakin You
Ketsakin You
FRFourat Ridouani
Fourat Ridouani
JMJean Marzelle
Jean Marzelle
HKHicham Kobeiter
Hicham Kobeiter

1 August 2020 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
FRFourat Ridouani
Fourat Ridouani
SSStephen B. Solomon
Stephen B. Solomon
YBYolanda Bryce
Yolanda Bryce
JBJacqueline F. Bromberg
Jacqueline F. Bromberg
CSConstantinos T. Sofocleous
Constantinos T. Sofocleous
ADAmy Deipolyi
Amy Deipolyi

15 November 2019 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
ADAmy Deipolyi
Amy Deipolyi
RERyan W. England
Ryan W. England
FRFourat Ridouani
Fourat Ridouani
CRChristopher C. Riedl
Christopher C. Riedl
HKHenry S. Kunin
Henry S. Kunin
CSConstantinos T. Sofocleous
Constantinos T. Sofocleous